Sign in
TerminatedNo phase

Improving Aspirin Prescription Rates in Outpatient Clinic

Key facts

Who runs it
Cairo University
Where
Kuwait1 site in 1 countryChoose a country to see its sites
Trial code
Status
Terminated
People taking part
300 people enrolled
Started
1 Nov 2024
Ended
30 Apr 2025
Type of study
Observational
Treatments tested
  • Aspirin prescription on outpatient basis
Record updated
10 July 2025
Why it stopped
Could not obtain ethical approval yet

Who can take part

Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Women at high risk are those with any of the following:
  • hypertensive disease during a previous pregnancy
  • chronic kidney disease
  • autoimmune disease such as systemic lupus erythematosus or antiphospholipid syndrome
  • type 1 or type 2 diabetes
  • chronic hypertension; Women with more than one moderate risk factor, such as are:
  • nulliparity
  • age 40 years or older
  • pregnancy interval of more than 10 years
  • body mass index (BMI) of 35 kg/m2 or more at first visit
  • family history of pre-eclampsia
  • multi-fetal pregnancy

Who cannot take part

  • None. All eligible candidates will be included

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Ρrееςlаmpѕia is a syndrome characterised by the new onset of hуреrtеnѕion plus proteinuria, end-organ dysfunction, or both after 20 weeks of gestation. It complicates 3-5% of pregnancies.

Read full original descriptionShow less

Low-dose aspirin reduces the frequency of рrееςlampsia, as well as related adverse рrеgոaոcy outcomes (preterm birth, growth restriction), by 10 to 70% when taken by patients аt moderate to high risk of the disease. It has an excellent maternal/fetal safety profile. Thus, it is a reasonable preventive strategy for these patients.

A pilot study at our hospital found that not all patients who are candidates for aspirin prescription receive it (only 40%). This audit cycle aims to increase aspirin prescription rates for moderate and high-risk obstetric populations.

The group in the trial

  • Obstetric population candidate for aspirin prescription

    Moderate- and high-risk obstetric population

    Treatment: Aspirin prescription on outpatient basis

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Aspirin Prescription For Moderate- and High-Risk Obstetric Population in Outpatient Clnic; A Quality Improvement Project.
Record updated
10 July 2025